Real-time enrollment status for this recurrent waldenstrom macroglobulinemia clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 1:20 AM UTC
| NCT Number | NCT07420959 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Waldenstrom Macroglobulinemia |
| Phase | PHASE1 |
| Target Enrollment | 38 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT07420959 is currently recruiting participants. This phase1 study for recurrent waldenstrom macroglobulinemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07420959 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07420959 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.